Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults diagnosed with Parkinson's disease who are being cared for at Grenoble University Hospital and for whom doctors have determined that brain stimulation surgery (placing electrodes deep in a specific area of the brain) is the right treatment option.
- People who have agreed to be fitted with a specific type of brain stimulator made by Medtronic, called a PERCEPT device, as part of their standard care.
- People who have been fully informed about the trial and have signed a consent form agreeing to take part.
- People who are covered by French social security or an equivalent insurance scheme.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who do not speak or understand French, as the trial involves completing questionnaires that require it.
- People who have a condition — such as dementia or severe depression — that, in the opinion of the doctor running the trial, could prevent them from safely or fully completing the study.
- People who are currently excluded from participating in other studies.
- People who fall under a legally protected category as defined by specific articles of the French Public Health Code (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of specific electrophysiological markers of different sleep stages; Identification of sleep disorders based on the activity of the subthalamic nucleus
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.